Emageon evaluating strategic options?perhaps a sale?

Twitter icon
Facebook icon
LinkedIn icon
e-mail icon
Google icon

Emageon, a provider of medical IT systems for hospitals, healthcare networks and imaging facilities, has reported that the strategic alternatives committee of its board of directors plans to evaluate its available strategic options, which could indicate a potential sale of the company.

To that end, the company has chosen Jefferies and Company, an investment bank and institutional securities firm, to act in a lead advisory capacity.
SunTrust Robinson Humphrey, which provides capital raising, strategic advisory, risk management and investment proposals, has been appointed to co-advise, according to the Birmingham, Ala.-based company.

Emageon lost $4.6 million in the first quarter of 2008 as revenue dropped 30 percent to $19.3 million, and also recently settled a proxy contest with New York City-based Oliver Press Partners, a major shareholder. The settlement has caused a shake-up within Emageon’s board of directors.